Keywords: epogen, sales, slowing, amgen, net, income, rose

Epogen sales slowing at Amgen

Article | 01 November 2000

Print This

Amgen's net income rose 20% to $359 million for the third quarter of2000 as total revenues reached $950 million (+12%). Growth was driven by ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in